<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Whole slide | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/digital-pathology-news/whole-slide/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Mon, 06 Apr 2026 13:05:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Whole slide | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Pictor Labs Introduces On-Prem Deployment for Virtual Stains at USCAP 2026</title>
		<link>https://tissuepathology.com/2026/04/06/pictor-labs-introduces-on-prem-deployment-for-virtual-stains-at-uscap-2026/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 06 Apr 2026 13:05:44 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Web/Tech]]></category>
		<category><![CDATA[Whole slide]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[On-Prem Deployment system]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Pictor Labs]]></category>
		<category><![CDATA[USCAP 2026]]></category>
		<category><![CDATA[Virtual Stains]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24331</guid>

					<description><![CDATA[<p>Pictor Labs: AI-Powered Virtual Staining Can Now Run Directly Within Pathology Labs First-to-market, production-ready On-Prem deployment system enables secure, high-speed virtual staining without transmitting data to external cloud infrastructure Visit Pictor Labs at Booth #749 for a hands-on demonstration LOS ANGELES, March 23, 2026 /PRNewswire/ &#8212; Pictor Labs, the virtual staining company, enabling digital pathology adoption worldwide, today [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/04/06/pictor-labs-introduces-on-prem-deployment-for-virtual-stains-at-uscap-2026/">Pictor Labs Introduces On-Prem Deployment for Virtual Stains at USCAP 2026</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Ataraxis AI Launches Ataraxis Breast CTX, the First Predictive AI Test Estimating Individualized Chemotherapy Benefit in Breast Cancer</title>
		<link>https://tissuepathology.com/2026/03/31/ataraxis-ai-launches-ataraxis-breast-ctx-the-first-predictive-ai-test-estimating-individualized-chemotherapy-benefit-in-breast-cancer/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 31 Mar 2026 13:37:57 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Whole slide]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Ataraxis AI]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Digital Slides]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[oncology]]></category>
		<category><![CDATA[Pathology]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24318</guid>

					<description><![CDATA[<p>NEW YORK&#8211;(BUSINESS WIRE)&#8211;Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis™ Breast CTX, a new predictive capability within its Ataraxis Breast platform, designed to help estimate individualized chemotherapy benefit in breast cancer patients. Ataraxis Breast combines digitized H&#38;E pathology slides with clinical data to generate prognostic and [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/03/31/ataraxis-ai-launches-ataraxis-breast-ctx-the-first-predictive-ai-test-estimating-individualized-chemotherapy-benefit-in-breast-cancer/">Ataraxis AI Launches Ataraxis Breast CTX, the First Predictive AI Test Estimating Individualized Chemotherapy Benefit in Breast Cancer</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Tempus Announces the Launch of Paige Predict</title>
		<link>https://tissuepathology.com/2026/01/21/tempus-announces-the-launch-of-paige-predict/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 21 Jan 2026 14:46:17 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Whole slide]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[biomarker prediction]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[hematoxylin and eosin (H&E)]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Paige]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Tempus]]></category>
		<category><![CDATA[Whole Slide]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24186</guid>

					<description><![CDATA[<p>Following the acquisition of Paige in 2025, Tempus launches its new AI-powered, biomarker prediction solution for digital pathology CHICAGO&#8211;(BUSINESS WIRE)&#8211;Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of Paige Predict, a suite of cutting-edge digital pathology applications that analyze hematoxylin and eosin [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/01/21/tempus-announces-the-launch-of-paige-predict/">Tempus Announces the Launch of Paige Predict</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>INFINITT North America Expands Digital Pathology Portfolio with FDA-Cleared Hamamatsu S360MD Scanner Integration</title>
		<link>https://tissuepathology.com/2025/12/19/infinitt-north-america-expands-digital-pathology-portfolio-with-fda-cleared-hamamatsu-s360md-scanner-integration/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 19 Dec 2025 13:58:00 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Whole slide]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[FFPE tissue]]></category>
		<category><![CDATA[hamamatsu]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[INFINITT North America]]></category>
		<category><![CDATA[NDPI]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[scanner]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24124</guid>

					<description><![CDATA[<p>INFINITT North America, a leader in advanced healthcare imaging solutions, is excited to announce the newest addition to its digital pathology platform: the FDA-cleared Hamamatsu NanoZoomer S360MD Slide Scanner, now seamlessly integrated with the INFINITT Digital Pathology Solution (DPS). This milestone solidifies INFINITT&#8217;s position among the digital pathology sector&#8217;s top innovators and signals a new [&#8230;]</p>
The post <a href="https://tissuepathology.com/2025/12/19/infinitt-north-america-expands-digital-pathology-portfolio-with-fda-cleared-hamamatsu-s360md-scanner-integration/">INFINITT North America Expands Digital Pathology Portfolio with FDA-Cleared Hamamatsu S360MD Scanner Integration</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems</title>
		<link>https://tissuepathology.com/2025/12/05/indica-labs-receives-fda-clearance-for-enterprise-digital-pathology-platform-with-industry-leading-dicom-compatible-aperio-scanner-from-leica-biosystems/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 05 Dec 2025 14:47:13 +0000</pubDate>
				<category><![CDATA[Anatomic Pathology]]></category>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Clinical Pathology]]></category>
		<category><![CDATA[Device Manufacturers]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Whole slide]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[anatomic pathology]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[DICOM]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[FDA 510(k) Clearance]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[In Vitro]]></category>
		<category><![CDATA[Indica Labs]]></category>
		<category><![CDATA[leica biosystems]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[scanner]]></category>
		<category><![CDATA[SVS]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24097</guid>

					<description><![CDATA[<p>Indica Labs’ HALO AP Dx digital pathology platform for primary diagnostics has received FDA 510(k) clearance with Leica Biosystems’ Aperio GT 450 DX Scanner and is cleared for use with both SVS and DICOM file formats. ALBUQUERQUE, NM, and VISTA, CA, December 3, 2025 – Indica Labs, the global leader of AI-powered digital pathology, and Leica [&#8230;]</p>
The post <a href="https://tissuepathology.com/2025/12/05/indica-labs-receives-fda-clearance-for-enterprise-digital-pathology-platform-with-industry-leading-dicom-compatible-aperio-scanner-from-leica-biosystems/">Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Tribun Health: Behind the Scenes of Building an AI Algorithm in Digital Pathology</title>
		<link>https://tissuepathology.com/2025/11/17/tribun-health-behind-the-scenes-of-building-an-ai-algorithm-in-digital-pathology/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 17 Nov 2025 12:58:13 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Whole slide]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Algorithms]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Software]]></category>
		<category><![CDATA[Tribun health]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24049</guid>

					<description><![CDATA[<p>From the Tribun Health blog: When a pathologist opens a digital slide and clicks to get a fast, accurate analysis, it seems effortless. Within seconds, AI detects cells, quantifies biomarkers, or suggests a score. Almost magical. But behind every prediction lies a long, collaborative process involving medical expertise, data science, and technical precision. In this [&#8230;]</p>
The post <a href="https://tissuepathology.com/2025/11/17/tribun-health-behind-the-scenes-of-building-an-ai-algorithm-in-digital-pathology/">Tribun Health: Behind the Scenes of Building an AI Algorithm in Digital Pathology</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
